Global Blood and Fluid Warmer Market - 2022-2029

Global Blood and Fluid Warmer Market - 2022-2029

Market Overview

Blood and Fluid Warmer Market are expected to grow at a CAGR of 9.2% during the forecasting period (2022-2029).

Blood warmer devices are used to warm the blood or fluids prior to transferring blood to an individual. It usually works by warming the blood to a temperature that is considered safe for infusion. The device is mainly used in ICUs, hospitals, clinics, clinical institutions, and operating rooms to prevent hypothermic conditions. There are a few exceptional features that enable ease of accessibility, portability, and patient comfort.

Market Dynamics

The global blood and the fluid warmer market is driven by the growing burden of hypothermia cases, increasing number of surgeries along with an aging population, an increasing number of trauma cases, rising consumption of drugs, and increasing prevalence of thyroid and diabetes.

The growing prevalence of thyroid and diabetes is expected to drive the market growth

The growing prevalence of thyroid and diabetes is expected to drive the market over the period of forecast. The American Thyroid Association (ATA) is the world’s leading professional association of medical specialists dedicated to education and research to improve thyroid disease prevention. According to data for 2021, provided by the organization, more than 12 percent of the U.S. population will develop this disease during their lifetime. An estimated 20 million Americans have some form of thyroid disease. Up to 60 percent of those with thyroid disease are unaware of their condition. Women are five to eight times more likely than men to have thyroid problems. Undiagnosed thyroid disease may put patients at risk for certain serious conditions, such as cardiovascular diseases, osteoporosis, and infertility.

According to the data provided by National Diabetes Statistics Report, 2020, 26.9 million people of all ages, or 8.2% of the US population had been diagnosed with diabetes. This includes 187,000 with type 1 diabetes. both having type 1 diabetes and using insulin. This factor is driving the growth of the market in the forecast period.

The complications related to blood warmer devices will hamper the growth of the market

However, the complications related to blood warmer devices, heavy research and development expenses in product development, and lower awareness about blood and fluid warming instruments are expected to hamper the global blood and fluid warmer market.

COVID-19 Impact Analysis

Countries around the world face a major public health concern with the current outbreak of the novel (new) coronavirus (COVID-19). In an effort to serve its patients who are suffering from hematology-related conditions. Furthermore, blood hypercoagulability is common among hospitalized COVID‐19 patients. Elevated D‐Dimer levels are consistently reported, whereas their gradual increase during the disease course is particularly associated with disease worsening. The COVID‐19 infected patients, whether hospitalized or ambulatory, are at high risk for venous thromboembolism, and an early and prolonged pharmacological thromboprophylaxis with low molecular weight heparin is highly recommended. Thus the pandemic will impact the market during the first quarter of 2020 but in the year 2022, the situation is fine, and thus the market will grow at a moderate rate during the forecast period.

Segment Analysis/B>

The intravenous warming system segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

An intravenous warming system is expected to drive the market over the period of forecast, owing to the new launches and added advantages of the system. Intravenous fluid warming is an alternative warming method that prevents hypothermia in patients who require a massive fluid transfusion. Its use assists in keeping a patient's body temperature in a normal range and helps to prevent hypothermia. Hypothermia had been documented to produce numerous unwanted and clinically undesirable results in patients especially those undergoing surgery. In 60-90% of all surgical patients, hypothermia has occurred. Using the intravenous warming system assists in reducing and eliminating hypothermia in the surgical patient. Thus, the growing number of surgeries across the world is driving the growth of the market in the forecast period.

Geographical Analysis

North America region holds the largest market share of the global blood and fluid warmer market

North America dominates the market for blood and fluid warmer and is expected to show a similar trend over the forecast period. The North American market's growth can be attributed to the increasing incidence of hypothermia, rising adoption of blood-warming systems, a growing volume of surgical procedures, and the rising number of trauma cases in the region as compared to other areas. The increasing number of trauma cases in the region is expected to drive the market. For instance, according to the American Association for Surgery of trauma, in 2020 trauma is one of the leading causes of death for people up to the age of 45 years old. It is the 4th leading cause of death overall for all ages. There are 40,000 homicide and suicide deaths each year in the US.

The growing volume of surgical procedures in the region is expected to drive the market. For instance, as per the American Hospital Association, there are 59,281 surgical beds available in the United States. According to the PUBMED, surgical procedure volume during the 2020 initial COVID-19-related shutdown and subsequent fall and winter infection surge were compared with volume in 2019 but it was again growing in 2021. Therefore, the growing surgical procedure is driving the growth of the market in the forecast period.

Competitive Landscape

The blood and the fluid warmer market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Becton Dickinson, Smiths Medical, 3M, Stryker, GE Healthcare, Paragon Medical, Sino Medical Device Technology, Geratherm Medical A, The 370Company, and Baxter among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the blood and fluid warmer market globally. For instance, in April 2021, Danish MedTech Company, MEQU, launched an in-hospital solution, M Station, for its blood and IV fluid warming device, M Warmer System.

Vyaire Medical Inc.

Overview:

Vyaire Medical, Inc. distributes and produces medical equipment. Vyaire offers oxygen blenders, resuscitation devices, ventilators, anesthesia breathing circuits, nebulizers, carbon monoxide monitors, spirometers, and other equipment. Vyaire Medical serves customers worldwide.

Product Portfolio:

enFlow: The enFlow system delivers the right temperature in the right place at the right time. The enFlow IV fluid/blood warming system consists of the enFlow Warmer (Model 100 series), the enFlow Controller (Model 121 series), and the enFlow. Disposable Cartridge with IV extension set (Model 202) or without IV extension set (Model 200). Within seconds, this warming system delivers normothermic infuscate to the patient at flow rates of Keep Vein Open (KVO defined as 2 mL/min) to 200 mL/min when input fluid temperature is 20 °C.

The global blood and fluid warmer market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.